首页 / 产品 / 抗体 / 一抗

Rabbit Monoclonal MyelinBasicProtein Antibody

  • 中文名: Myelin Basic Protein抗体
  • 别    名: Myelin membrane encephalitogenic protein; Myelin A1 protein
货号: IPDX21703
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 1/500-1/1000 Mouse,Rat
IF 咨询技术 Mouse,Rat
IHC 咨询技术 Mouse,Rat
ICC 技术咨询 Mouse,Rat
FCM 咨询技术 Mouse,Rat
Elisa 咨询技术 Mouse,Rat

产品详情

AliasesMyelin membrane encephalitogenic protein; Myelin A1 protein
Entrez GeneID4155
WB Predicted band sizeCalculated MW: 33 kDa; Observed MW: 18 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityMouse,Rat
ImmunogenA synthetic peptide of human Myelin Basic Protein
FormulationPurified antibody in TBS with 0.05% sodium azide,0.05%BSA and 50% glycerol.

+ +

参考文献

以下是关于Myelin Basic Protein(MBP)抗体的3篇参考文献的简要概括:

---

1. **标题**: *Autoantibodies to myelin basic protein in multiple sclerosis patients: biological and clinical implications*

**作者**: Warren KG et al.

**摘要**: 研究探讨了多发性硬化症(MS)患者血清中MBP自身抗体的存在及其与疾病活动性的关联,发现抗体水平与急性复发阶段相关,提示其可能参与髓鞘破坏的病理过程。

---

2. **标题**: *Immunoassay-based detection of Myelin Basic Protein in rodent models of demyelination*

**作者**: Smith CE et al.

**摘要**: 开发了一种高灵敏度的ELISA方法,利用MBP特异性抗体检测实验性自身免疫性脑脊髓炎(EAE)小鼠模型中的MBP水平,为评估脱髓鞘和再髓鞘化提供了定量工具。

---

3. **标题**: *Anti-MBP antibodies as a biomarker in cerebrospinal fluid of pediatric neurological disorders*

**作者**: Tanaka M et al.

**摘要**: 分析了儿童神经疾病患者脑脊液中的MBP抗体,发现其在急性播散性脑脊髓炎(ADEM)中显著升高,表明其可作为鉴别诊断和疾病监测的潜在标志物。

---

这些文献涵盖了MBP抗体在疾病机制、实验模型和临床诊断中的应用方向,供参考。如需全文链接或补充内容,可进一步提供详细信息。

背景信息

Myelin Basic Protein (MBP) antibodies are autoantibodies targeting MBP, a key structural component of the myelin sheath that insulates nerve fibers in the central and peripheral nervous systems. MBP, produced by oligodendrocytes and Schwann cells, plays a critical role in maintaining myelin stability and facilitating efficient nerve signal transmission. The detection of MBP antibodies has been extensively studied in demyelinating disorders, particularly multiple sclerosis (MS), where autoimmune-mediated damage to myelin is a hallmark.

Historically, MBP antibodies were identified in the serum and cerebrospinal fluid (CSF) of MS patients, suggesting their potential role in disease pathogenesis. However, their diagnostic and prognostic utility remains controversial due to variable sensitivity and specificity. While elevated MBP antibody levels may correlate with acute demyelination episodes or disease activity, they are not exclusive to MS and can appear in other conditions like acute disseminated encephalomyelitis (ADEM) or neuromyelitis optica spectrum disorders (NMOSD).

In research, MBP antibodies are tools for studying demyelination mechanisms. Experimental autoimmune encephalomyelitis (EAE), an MS animal model, is induced by immunizing animals with MBP, triggering immune responses that mimic human disease. Clinically, MBP antibody assays (e.g., ELISA, Western blot) are less commonly used today, overshadowed by more specific biomarkers like anti-AQP4 or anti-MOG antibodies. Nonetheless, MBP antibodies remain relevant in understanding autoimmune neuropathology and exploring therapeutic strategies targeting myelin repair.

客户数据及评论

折叠内容

大包装询价

×